BioNTech SE annual r&d spending
2017
2018
2019
2020
2021
2022
2023
2024
2025
BioNTech SE R&D Spending Growth & History (BNTX)
BioNTech SE's r&d spending was €2.10B for fiscal 2025.
View full BioNTech SE company overviewBioNTech SE annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.10B | −€149.3M | −6.62% |
| 2024 | 2024-12-31 | €2.25B | €471.1M | +26.42% |
| 2023 | 2023-12-31 | €1.78B | €246.1M | +16.01% |
| 2022 | 2022-12-31 | €1.54B | €587.8M | +61.93% |
| 2021 | 2021-12-31 | €949.2M | €304.2M | +47.16% |
| 2020 | 2020-12-31 | €645.0M | €418.5M | +184.77% |
| 2019 | 2019-12-31 | €226.5M | €83.5M | +58.35% |
| 2018 | 2018-12-31 | €143.0M | €57.5M | +67.31% |
| 2017 | 2017-12-31 | €85.5M | — | — |
BioNTech SE quarterly r&d spending
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €551.0M | €41.9M | +8.23% |
| Q1 2026 | 2026-03-31 | €557.0M | — | — |
| Q4 2025 | 2025-12-31 | €505.4M | — | — |
| Q3 2025 | 2025-09-30 | €564.8M | — | — |
| Q2 2025 | 2025-06-30 | €509.1M | — | — |
BioNTech SE r&d spending trends
Over the last five fiscal years, BioNTech SE's r&d spending increased from €645.0M to €2.10B, a change of €1.46B. The latest reported quarter, Q2 2026, shows €551.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioNTech SE source filings ↗